Insider Buying: Nanalysis Scientific Corp. (CVE:NSCI) Director Acquires C$19,000.00 in Stock

Nanalysis Scientific Corp. (CVE:NSCI) Director Sean Edward Krakiwsky acquired 50,000 shares of the company’s stock in a transaction dated Monday, September 16th. The shares were purchased at an average cost of C$0.38 per share, for a total transaction of C$19,000.00.

Nanalysis Scientific Stock Performance

Shares of CVE NSCI opened at C$0.40 on Thursday. The company has a market capitalization of C$45.22 million, a PE ratio of -3.33 and a beta of 0.74. The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.11 and a current ratio of 1.42. The company’s fifty day moving average price is C$0.40 and its 200 day moving average price is C$0.42. Nanalysis Scientific Corp. has a 1 year low of C$0.33 and a 1 year high of C$0.60.

About Nanalysis Scientific

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.